Clinical and Etiological Characteristics of Community-Acquired Pneumonia at High Altitudes in Tibet, China

Qucuo Meilang,Ran Li,Xue-Mei Wu,Ying Shang,Pu Ning,Jing Bao,Qiongda Bianba,Zhuoga Pubu,Li-Ping Huang,Zhan-Cheng Gao
DOI: https://doi.org/10.1097/cm9.0000000000001166
IF: 6.133
2020-01-01
Chinese Medical Journal
Abstract:To the Editor: Community-acquired pneumonia (CAP) is one of the most common infectious diseases, causing high morbidity and mortality. High altitudes are characterized by a hypoxic environment with low barometric pressure, increased ultraviolet radiation, and low humidity. Hypoxia can disturb normal homeostasis of the immune system, especially impairing the function of the T lymphocytes, leading to an increased susceptibility to bacterial infection. The respiratory symptoms of CAP at high altitudes are similar to that of high-altitude pulmonary edema.However, the occurrence of CAP can exacerbate high-altitude pulmonary edema. Few published data of CAP in adults at high altitudes have been reported worldwide. Tibet is locatedat anaveragealtitudeofover3000mabove sea level, and the clinical and etiological data of CAP at high altitudes are lacking. Almost all the nationwide epidemiological studies of CAP inChina have excluded high-altitude regions (>2500m). Currently, there is no difference between the management strategies of CAP in Tibet and low-altitude regions, with similar CAP guidelines applied in clinical practice. The special environmental conditions at high altitudes may influence the etiology of CAP; hence, the optimal strategy for the treatment of CAP needs to be investigated in accordance with the local circumstances. Moreover, tuberculosis is prevalent in Tibet with atypical clinical manifestations and is sometimes difficult to distinguish from CAP exclusively based on clinical features without microbiological evaluation. The high prevalence of prior tuberculosis infection further complicates the diagnosis of CAP. We conducted a pilot study of CAP at a single center in Tibet to understand the clinical profile of CAP at high altitudes and optimize the treatment strategy for the management of CAP at high altitudes.
What problem does this paper attempt to address?